Gérard Botton

Title: Gérard Botton: Innovator in Pharmaceutical Chemistry

Introduction

Gérard Botton is a notable inventor based in Buc, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents for diabetes. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Gérard Botton's latest patents include innovative compounds and methods. One of his patents focuses on Thiazolidone-2 derivatives, specifically 4-diketone substituted, along with a method for obtaining them and pharmaceutical compositions containing these compounds. Another significant patent involves 4-(1-piperazinyl) benzoic acid derivatives, detailing the process for preparing them and their therapeutic applications. These new derivatives are particularly noted for their potential use in treating diabetes.

Career Highlights

Throughout his career, Gérard Botton has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Patent Gesellschaft mit Beschränkter Haftung and Merck Patent GmbH, where he contributed to various innovative projects and research initiatives.

Collaborations

Gérard Botton has collaborated with esteemed colleagues in his field, including Gérard Moinet and Liliane Doare. Their joint efforts have further advanced the research and development of pharmaceutical compounds.

Conclusion

Gérard Botton's contributions to pharmaceutical chemistry, particularly in diabetes treatment, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to innovation in the medical field.